Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-010942
Filing Date
2020-02-05
Accepted
2020-02-05 06:05:10
Documents
1
Period of Report
2020-01-31

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 11033
  Complete submission text file 0001104659-20-010942.txt   12470
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

IRS No.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Whelan, Jr. Robert M. (Reporting) CIK: 0001490045 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39202 | Film No.: 20576284